Suchergebnisse - "Gao, Leili"

PubPharm (6)

1

A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy

enthalten in: Diabetes, obesity & metabolism | 2023

von Ji, L. | Lu, J. | Gao, L. | +12

2

Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes : A randomized, double-blind, placebo-controlled phase 3 trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Ji, L. | Lu, J. | Gao, L. | +12

3

Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region : the SURPASS-AP-Combo trial

enthalten in: Nature medicine | 2023

von Gao, L. | Lee, B. | Chawla, M. | +5

4

A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology

enthalten in: Diabetes | 2023

von Ren, Q. | Zhang, P. | Pang, W. | +14

5

Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Gao, L. | Cheng, Z. | Su, B. | +15

6

A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus : A study protocol

enthalten in: Diabetes, obesity & metabolism | 2023

von Du, Y. | Gao, L. | Xiao, X. | +2

1
[1]